![Blake Wise](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Blake Wise
Nessuna posizione attualmente
Profilo
Blake Wise formerly worked at Achaogen, Inc., as Chief Executive Officer & Director from 2017 to 2019, Novome Biotechnologies, Inc., as Chief Executive Officer & Director from 2019 to 2024, Genentech, Inc., as Senior Director, and Calithera Biosciences, Inc., as Independent Director.
Mr. Wise received his undergraduate degree from the University of California, Santa Barbara and Masters Business Admin degree from Haas School of Business.
Precedenti posizioni note di Blake Wise
| Società | Posizione | Fine |
|---|---|---|
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell-based therapeutics through the engineering of commensal gut microbes | Amministratore Delegato | 01/06/2024 |
| ACHAOGEN | Amministratore Delegato | 01/12/2019 |
| CALITHERA BIOSCIENCES, INC. | Direttore/Membro del Consiglio | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Formazione di Blake Wise
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
32
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calithera Biosciences, Inc.
 Calithera Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics to control cancer and other diseases | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell-based therapeutics through the engineering of commensal gut microbes | Commercial Services |
